Physician
Internal Medicine
Dr. Renumathy Dhanasekaran, MD
|
|
Give Review
Renumathy Dhanasekaran, MD works in the field of Internal Medicine. He went to medical school at Bangalore Medical College. Renumathy Dhanasekaran is also published. He has 17 publications published. The lastest publication: "Clinical implications of basic research in hepatocellular carcinoma.' Renumathy Dhanasekaran accepts Medicare.
Publications
- Clinical implications of basic research in hepatocellular carcinoma.
- Impact of fibrosis progression on clinical outcome in patients treated for post- transplant hepatitis C recurrence.
- Activation of the TGFβ/SMAD transcriptional pathway underlies a novel tumor promoting role of sulfatase1 in hepatocellular carcinoma.
- VASP promotes TGF-β activation of hepatic stellate cells by regulating Rab11 dependent plasma membrane targeting of TGF-β receptors.
- Challenges of recurrent hepatitis C in the liver transplant patient.
- Response to houlihan et Al.
- Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma.
- Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.
- Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation.
- Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver Transplantation.
- Liver Test Results Do Not Identify Liver Disease in Adults With α(1)-Antitrypsin Deficiency.
- Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy.
- The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
- Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary ...
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcin...
- Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- Blue Cross Blue Shield
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
Education
-
Mayo School of Graduate Medical Education -
University of Florida -
Bangalore Medical College
Hospital
-
Mayo Clinic - Rochester, Minnesota -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1609008143 | |
| NPPES Provider LastName | DHANASEKARAN | |
| NPPES Provider FirstName | RENUMATHY | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 93.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609008143 |
| Last Name Of The Provider | DHANASEKARAN |
| First Name Of The Provider | RENUMATHY |
| View All |
Similar Doctors
|
|
Dr. Maria K. Poirier, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason H. Szostek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cyril Varghese, MD |
|
|
Dr. Timothy W. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Bisig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wayne L. Feyereisn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin C. Fleming, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Suparna Chandra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea J. Zimmer, MD |